Your browser doesn't support javascript.
loading
Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer.
Kloth, Michael; Ruesseler, Vanessa; Engel, Christoph; Koenig, Katharina; Peifer, Martin; Mariotti, Erika; Kuenstlinger, Helen; Florin, Alexandra; Rommerscheidt-Fuss, Ursula; Koitzsch, Ulrike; Wodtke, Claudia; Ueckeroth, Frank; Holzapfel, Stefanie; Aretz, Stefan; Propping, Peter; Loeffler, Markus; Merkelbach-Bruse, Sabine; Odenthal, Margarete; Friedrichs, Nicolaus; Heukamp, Lukas Carl; Zander, Thomas; Buettner, Reinhard.
  • Kloth M; Institute of Pathology, Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Ruesseler V; Institute of Pathology, Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Engel C; Institute of Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
  • Koenig K; Institute of Pathology, Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Peifer M; Department of Translational Genomics, Centre for Molecular Medicine Cologne, Cologne, Germany.
  • Mariotti E; Department of Translational Genomics, Centre for Molecular Medicine Cologne, Cologne, Germany.
  • Kuenstlinger H; Institute of Pathology, Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Florin A; Institute of Pathology, Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Rommerscheidt-Fuss U; Institute of Pathology, Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Koitzsch U; Institute of Pathology, Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Wodtke C; Institute of Pathology, Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Ueckeroth F; Institute of Pathology, Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Holzapfel S; Institute of Human Genetics, University Hospital Bonn, Bonn, Germany.
  • Aretz S; Institute of Human Genetics, University Hospital Bonn, Bonn, Germany.
  • Propping P; Institute of Human Genetics, University Hospital Bonn, Bonn, Germany.
  • Loeffler M; Institute of Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
  • Merkelbach-Bruse S; Institute of Pathology, Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Odenthal M; Institute of Pathology, Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Friedrichs N; Institute of Pathology, Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Heukamp LC; Institute of Pathology, Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Zander T; Department of Internal Medicine I, Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Buettner R; Institute of Pathology, Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
Gut ; 65(8): 1296-305, 2016 08.
Article en En | MEDLINE | ID: mdl-26001389
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Neoplasias Colorrectales Hereditarias sin Poliposis / Receptor ErbB-2 / Receptores ErbB / Cetuximab / Trastuzumab Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Neoplasias Colorrectales Hereditarias sin Poliposis / Receptor ErbB-2 / Receptores ErbB / Cetuximab / Trastuzumab Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2016 Tipo del documento: Article